|
| |
| | | 68628 | | 12.12.2023 | | Sandoz Pharmaceuticals AG | | | | | | | 11.12.2028 | | | | | | 01.06. | | | | 01.06. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Bupropion XR Sandoz 150 mg | Retardtabletten | Delayed release tablets (Bupropion Hydrochloride 150 mg) | N06AX12 | CI | | 02 | Bupropion XR Sandoz 300 mg | Retardtabletten | Delayed release tablets (Bupropion Hydrochloride 300 mg) | N06AX12 | |
|
|
|
